- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00733291
Evaluation of Daily Disposable Lenses With Multi-Purpose Solution (MPS)
December 21, 2011 updated by: Alcon Research
The purpose of this study is to evaluate daily disposable lenses inserted out of the blister package versus daily disposable lenses inserted after a pre-soak in Multi-purpose solution FID 107027.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Corneal staining and subjective responses for ocular redness and comfort will be compared.
Study Type
Interventional
Enrollment (Actual)
64
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Fort Worth, Texas, United States, 76134
- Contact Alcon Call Center for Trial Locations
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18 years of age or older.
- Visual acuity correctable to 20/30 (Snellen) or better in each eye at distance with contact lenses.
- Successfully wearing hydrogel or silicone hydrogel contact lenses on a daily wear basis for at least two weeks prior to study.
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- History of hypersensitivity to any components of the multi-purpose solution.
- Evidence or history of ocular conditions as prescribed in protocol.
- One functional eye or a monofit lens
- Any slit-lamp finding score equal to 1 at Visit 1 of each study period.
- Significant corneal staining at visit 1 of each study period as prescribed in protocol.
- Other protocol-defined exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Nelfilcon A soak / Nelfilcon A no-soak
Nelfilcon A contact lenses inserted after being soaked overnight in a multi-purpose disinfecting solution, followed by nelfilcon A contact lenses inserted directly from the blister package.
Each pair of lenses worn for 2 hours.
|
Commercially marketed, single vision, soft contact lens for daily disposable wear
Other Names:
Commercially marketed solution for contact lens disinfection
Other Names:
|
|
Active Comparator: Nelfilcon A no soak / nelfilcon A soak
Nelfilcon A contact lenses inserted directly from the blister package, followed by nelfilcon A contact lenses inserted after being soaked overnight in a multi-purpose disinfecting solution.
Each pair of lenses worn for 2 hours.
|
Commercially marketed, single vision, soft contact lens for daily disposable wear
Other Names:
Commercially marketed solution for contact lens disinfection
Other Names:
|
|
Active Comparator: Etafilcon A soak / etafilcon A no soak
Etafilcon A contact lenses inserted after being soaked overnight in a multi-purpose disinfecting solution, followed by etafilcon A contact lenses inserted directly from the blister package.
Each pair of lenses worn for 2 hours.
|
Commercially marketed solution for contact lens disinfection
Other Names:
Commercially marketed, single vision, soft contact lens for daily disposable wear
Other Names:
|
|
Active Comparator: Etafilcon A no soak / etafilcon A soak
Etafilcon A contact lenses inserted directly from the blister package, followed by etafilcon A contact lenses inserted after being soaked overnight in a multi-purpose disinfecting solution.
Each pair of lenses worn for 2 hours.
|
Commercially marketed solution for contact lens disinfection
Other Names:
Commercially marketed, single vision, soft contact lens for daily disposable wear
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Average Corneal Staining Area
Time Frame: After 2 hours of wear
|
Percentage corneal staining was assessed by the investigator for each of five regions of the cornea, i.e., four quadrants plus central.
The investigator instilled fluorescein dye and examined the cornea with a slit lamp, i.e., biomicroscope and a yellow filter.
Percentage corneal staining area was recorded in increments of ten, and the percentages of the five regions were averaged together.
|
After 2 hours of wear
|
|
Total Corneal Staining Type
Time Frame: After 2 hours of wear
|
Total corneal staining type was assessed by the investigator for each of 5 regions of the cornea, i.e., four quadrants plus central.
The investigator instilled fluorescein dye and examined the cornea with a slit lamp, i.e., biomicroscope and a yellow filter.
Corneal staining type was recorded on a 5-point scale for each region: 0-none; 1-micropunctate; 2-macropunctate; 3-coalesced macropunctate; 4-patch (>/= 1mm).
The five regions were summed.
|
After 2 hours of wear
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ocular Comfort
Time Frame: After 2 hours of wear
|
Ocular comfort was recorded by the participant on a questionnaire using a 5-point scale.
Participant completed the sentence, "Right now my eyes feel..." with one of the following responses: 1-very comfortable; 2-comfortable; 3-neither comfortable nor uncomfortable; 4-uncomfortable; 5-very uncomfortable.
|
After 2 hours of wear
|
|
Ocular Redness
Time Frame: After two hours of wear
|
Ocular redness was recorded by the participant on a questionnaire using a 5-point scale.
Participant completed the sentence, "Right now my eyes look..." with one of the following responses: 1-very white; 2-white; 3-neither white nor red; 4-red; 5-very red.
|
After two hours of wear
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2008
Primary Completion (Actual)
February 1, 2008
Study Completion (Actual)
February 1, 2008
Study Registration Dates
First Submitted
August 11, 2008
First Submitted That Met QC Criteria
August 11, 2008
First Posted (Estimate)
August 13, 2008
Study Record Updates
Last Update Posted (Estimate)
December 28, 2011
Last Update Submitted That Met QC Criteria
December 21, 2011
Last Verified
December 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MS-008
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
He Eye HospitalNot yet recruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityActive, not recruiting
-
University Eye Hospital, FreiburgActive, not recruiting
-
University of BradfordUniversity of Huddersfield; CooperVision International Limited (CVIL)Enrolling by invitationMyopia, ProgressiveUnited Kingdom
Clinical Trials on Nelfilcon A contact lens
-
CIBA VISIONCompleted
-
CIBA VISIONCompleted
-
CIBA VISIONCompleted
-
CIBA VISIONCompletedAstigmatism | Myopia
-
Alcon ResearchCompletedRefractive Error | Presbyopia | Myopia | Ametropia
-
CIBA VISIONCompleted
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.Completed